Ticker Talk

Harvard Bioscience Inc. on Wednesday priced its initial public offering at $8 a share, below the $9 to $10 range it hoped to get. The biotech stock will begin trading today under the symbol HBIO on Nasdaq. . . .

For the second time in recent years, traders at the Chicago Board of Trade tossed out the incumbent chairman by a narrow margin in favor of a new leader. CBOT traders on Wednesday ousted incumbent chairman David Brennan and elected independent trader Nickolas Neubauer to carry on the task of restructuring the 152-year-old futures exchange.